Scientists test new drug duo in fight against tough cancers
NCT ID NCT03875820
Summary
This early-stage trial is testing the safety and best dose of a new two-drug combination for people with advanced solid tumors that have stopped responding to standard treatments. The study is focusing on specific cancers, including certain types of lung, ovarian, and pancreatic cancer. The goal is to see if the drugs can be given safely together and to gather initial information on how the body processes them.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Christie NHS Foundation Trust
Manchester, Greater Manchester, M20 4BX, United Kingdom
-
The Newcastle Upon Tyne Hospitals NHS Foundation Trust - Freeman Hospital
Newcastle, NE7 7DN, United Kingdom
-
The Royal Marsden NHS Foundation Trust
Sutton, Surrey, SM2 5PT, United Kingdom
-
The Royal Marsden NHS Foundation Trust - Gynecology Unit
London, SW3 6JJ, United Kingdom
-
The Royal Marsden NHS Foundation Trust - Gynecology Unit
Sutton, SM2 5PT, United Kingdom
Conditions
Explore the condition pages connected to this study.